Pancreatic beta cell heterogeneity in glucose-induced insulin secretion.

AbstractHeterogeneity of glucose-stimulated insulin secretion (GSIS) in pancreatic islets is physiologically important but poorly understood. Here, we utilize whole mouse islets to determine how microtubules affect secretion toward the vascular extracellular matrix. Our data indicate that microtubule stability in the β-cell population is heterogenous, and that cells with more stable microtubules secrete less in response to a stimulus. Consistently, microtubule hyper-stabilization prevents, and microtubule depolymerization promotes β-cell activation. Analysis of spatiotemporal patterns of secretion events shows that microtubule depolymerization activates otherwise dormant β-cells via initiation of secretion clusters (hot spots). Microtubule depolymerization also enhances secretion from individual cells, introducing both additional clusters and scattered events. Interestingly, without microtubules, the timing of clustered secretion is dysregulated, extending the first phase of GSIS. Our findings uncover a novel microtubule function in tuning insulin secretion hot spots, which leads to accurately measured and timed response to glucose stimuli and promotes functional β-cell heterogeneity.

Download Full-text

2072-P: Deletion of the Mitofusins 1 and 2 (Mfn1 and Mfn2) in the Pancreatic Beta Cell Disrupts Mitochondrial Structure and Function In Vitro and Strongly Impairs Glucose-Stimulated Insulin Secretion In Vivo

Diabetes ◽

10.2337/db20-2072-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2072-P

Author(s):

ELENI GEORGIADOU ◽

PAULINE L. CHABOSSEAU ◽

ALEJANDRA TOMAS ◽

ISABELLE LECLERC ◽

GUY A. RUTTER

Keyword(s):

Insulin Secretion ◽

Beta Cell ◽

Pancreatic Beta Cell ◽

Structure And Function ◽

Insulin Secretion In Vivo ◽

Mitochondrial Structure ◽

Glucose Stimulated Insulin Secretion ◽

And Function

Download Full-text

Faculty Opinions recommendation of High-throughput luminescent reporter of insulin secretion for discovering regulators of pancreatic Beta-cell function.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725299717.793502897 ◽

2015 ◽

Author(s):

Anna Gloyn ◽

Søren Krogsgaard Thomsen

Keyword(s):

Insulin Secretion ◽

Beta Cell ◽

High Throughput ◽

Beta Cell Function ◽

Cell Function ◽

Pancreatic Beta Cell ◽

Pancreatic Beta Cell Function

Download Full-text

What Is the Metabolic Amplification of Insulin Secretion and Is It (Still) Relevant?

Metabolites ◽

10.3390/metabo11060355 ◽

2021 ◽

Vol 11 (6) ◽

pp. 355

Author(s):

Ingo Rustenbeck ◽

Torben Schulze ◽

Mai Morsi ◽

Mohammed Alshafei ◽

Uwe Panten

Keyword(s):

Insulin Secretion ◽

Beta Cell ◽

Adenine Nucleotides ◽

Pancreatic Beta Cell ◽

Secretory Response ◽

Mitochondrial Activity ◽

Insulin Synthesis ◽

Sequence Of Events ◽

Insulin Granules

The pancreatic beta-cell transduces the availability of nutrients into the secretion of insulin. While this process is extensively modified by hormones and neurotransmitters, it is the availability of nutrients, above all glucose, which sets the process of insulin synthesis and secretion in motion. The central role of the mitochondria in this process was identified decades ago, but how changes in mitochondrial activity are coupled to the exocytosis of insulin granules is still incompletely understood. The identification of ATP-sensitive K+-channels provided the link between the level of adenine nucleotides and the electrical activity of the beta cell, but the depolarization-induced Ca2+-influx into the beta cells, although necessary for stimulated secretion, is not sufficient to generate the secretion pattern as produced by glucose and other nutrient secretagogues. The metabolic amplification of insulin secretion is thus the sequence of events that enables the secretory response to a nutrient secretagogue to exceed the secretory response to a purely depolarizing stimulus and is thus of prime importance. Since the cataplerotic export of mitochondrial metabolites is involved in this signaling, an orienting overview on the topic of nutrient secretagogues beyond glucose is included. Their judicious use may help to define better the nature of the signals and their mechanism of action.

Download Full-text

Pancreatic Beta-Cell Web: Its Possible Role in Insulin Secretion

Science ◽

10.1126/science.175.4026.1128 ◽

1972 ◽

Vol 175 (4026) ◽

pp. 1128-1130 ◽

Cited By ~ 244

Author(s):

L. Orci ◽

K. H. Gabbay ◽

W. J. Malaisse

Keyword(s):

Insulin Secretion ◽

Beta Cell ◽

Pancreatic Beta Cell ◽

Cell Web

Download Full-text

38-OR: Deletion of the Mitofusins 1 and 2 (Mfn1 and Mfn2) from the Pancreatic Beta Cell Disrupts Mitochondrial Structure and Impairs Glucose-, but Not Incretin-, Stimulated Insulin Secretion

Diabetes ◽

10.2337/db21-38-or ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 38-OR

Author(s):

ELENI GEORGIADOU ◽

CHARANYA MURALIDHARAN ◽

PAULINE L. CHABOSSEAU ◽

ALEJANDRA TOMAS ◽

THEODOROS STYLIANIDES ◽

...

Keyword(s):

Insulin Secretion ◽

Beta Cell ◽

Pancreatic Beta Cell ◽

Mitochondrial Structure

Download Full-text

Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation

AJP Endocrinology and Metabolism ◽

10.1152/ajpendo.1993.264.3.e441 ◽

1993 ◽

Vol 264 (3) ◽

pp. E441-E449 ◽

Cited By ~ 2

Author(s):

E. Christiansen ◽

H. B. Andersen ◽

K. Rasmussen ◽

N. J. Christensen ◽

K. Olgaard ◽

...

Keyword(s):

Insulin Secretion ◽

Glucose Metabolism ◽

Beta Cell ◽

Kidney Transplant ◽

Beta Cell Function ◽

Cell Function ◽

Pancreatic Beta Cell ◽

Secretion Rate ◽

C Peptide ◽

Insulin Secretion Rate

beta-Cell function and glucose metabolism were studied in eight insulin-dependent diabetic recipients of combined segmental pancreas and kidney transplant with peripheral insulin delivery (Px), in eight nondiabetic kidney-transplant individuals (Kx), and in eight normal subjects (Ns) after three consecutive mixed meals. All subjects had normal fasting plasma glucose, but increased basal levels of C-peptide were demonstrated in the transplant groups (P < 0.05 relative to Ns). Postprandial hyperglycemia was increased 14% in Kx and 32% in Px (P < 0.05), whereas compared with Ns postprandial C-peptide levels were increased three- and twofold, respectively, in Kx and Px (P < 0.05). Compared with Ns basal insulin secretion rate (combined model) was increased 2-fold in Kx and 1.4-fold in Px (P < 0.05). Maximal insulin secretion rate was reduced 25% in Px compared with Kx (P < 0.05) but not different from that of Ns (P NS). Also, maximal insulin secretion rate occurred later in Px than in controls (Tmax: Px 50 min, Kx 30 min, and Ns 32 min; P < 0.05). The total integrated insulin secretion was increased 1.4-fold in Px compared with Ns (P < 0.05) but decreased 1.4-fold compared with Kx (P < 0.05). Fasting and postprandial proinsulin-to-C-peptide molar ratios were inappropriately increased in Px compared with Kx and Ns. Basal hepatic glucose production was increased 43% in Px and 33% in Kx compared with Ns (P < 0.05). Postprandial total systemic glucose appearance was similar in all three groups, whereas peripheral glucose disposal was 15% reduced in Px (P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Download Full-text

High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line

Endocrine Regulations ◽

10.2478/enr-2018-0004 ◽

2018 ◽

Vol 52 (1) ◽

pp. 21-26 ◽

Cited By ~ 5

Author(s):

Eiji Yamato

Keyword(s):

Insulin Secretion ◽

Beta Cell ◽

Cell Line ◽

Beta Cells ◽

Pancreatic Beta Cells ◽

Pancreatic Beta Cell ◽

High Dose ◽

Min6 Cells ◽

Beta Cell Line ◽

High Doses

Abstract Objective. Histone deacytylase inhibitors (HDACis) inhibit the deacetylation of the lysine residue of proteins, including histones, and regulate the transcription of a variety of genes. Recently, HDACis have been used clinically as anti-cancer drugs and possible anti-diabetic drugs. Even though HDACis have been proven to protect the cytokine-induced damage of pancreatic beta cells, evidence also shows that high doses of HDACis are cytotoxic. In the present study, we, therefore, investigated the eff ect of HDACis on insulin secretion in a pancreatic beta cell line. Methods. Pancreatic beta cells MIN6 were treated with selected HDACis (trichostatin A, TSA; valproic acid, VPA; and sodium butyrate, NaB) in medium supplemented with 25 mM glucose and 13% heat-inactivated fetal bovine serum (FBS) for indicated time intervals. Protein expression of Pdx1 and Mafa in MIN6 cells was demonstrated by immunohistochemistry and immunocytochemistry, expression of Pdx1 and Mafa genes was measured by quantitative RT-PCR method. Insulin release from MIN6 cells and insulin cell content were estimated by ELISA kit. Superoxide production in MIN6 cells was measured using a Total ROS/Superoxide Detection System. Results. TSA, VPA, and NaB inhibited the expression of Pdx1 and Mafa genes and their products. TSA treatment led to beta cell malfunction, characterized by enhanced insulin secretion at 3 and 9 mM glucose, but impaired insulin secretion at 15 and 25 mM glucose. Th us, TSA induced dysregulation of the insulin secretion mechanism. TSA also enhanced reactive oxygen species production in pancreatic beta cells. Conclusions. Our results showed that HDACis caused failure to suppress insulin secretion at low glucose concentrations and enhance insulin secretion at high glucose concentrations. In other words, when these HDACis are used clinically, high doses of HDACis may cause hypoglycemia in the fasting state and hyperglycemia in the fed state. When using HDACis, physicians should, therefore, be aware of the capacity of these drugs to modulate the insulin secretory capacity of pancreatic beta cells.

Download Full-text